Inquire About a Product| Product: | Rimonabant-d10 | ||||
|---|---|---|---|---|---|
| Catalog Number: | D30781 | ||||
| CAS Number: | 929221-88-5 | ||||
| Synonyms: |
Acomplia-d10; SR 141716A-d10; SR 151716A-d10 |
||||
| Pricing: |
|
||||
| Formula: | C22H11D10Cl3N4O | ||||
| Molecular Weight: | 473.95 | ||||
| Structure: |
|
||||
| Category: | Aromatic Compounds | ||||
| Literature References: |
Fong TM, Heymsfield SB, Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions. Int J Obes (Lond), 2009, Sept; 33 (9): 947–55.; Keeney BK et al., Differential response to a selective cannabinoid receptor antagonist (SR141716: rimonabant) in female mice from lines selectively bred for high voluntary wheel-running behavior. Behavioural Pharmacology, 2008, 19 (8): 812–820.; Huestis MA et al., Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch. Gen. Psychiatry, 2001, 58 (4): 322–8. |
||||
| MSDS: | |||||
| Applications: | A labeled anorectic antiobesity drug. The drug has been pulled from the marked due to potentially serious side effects. An inverse agonist for the cannabinoid receptor CB1. Reduces appetite. May help assist smoker to quit smoking and possibly other addictions. Blocks the psychoactive and cardiovascular effects of THC. |